Drug Type Small molecule drug |
Synonyms Ceftezole, Ceftezole sodium (JAN), J01DB12 + [4] |
Target |
Action inhibitors |
Mechanism PBPs inhibitors(Bacterial penicillin-binding protein inhibitors), Cell wall inhibitors |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization- |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhaseApproved |
First Approval Date- |
Regulation- |
Molecular FormulaC13H12N8NaO4S3 |
InChIKeyLULDFGMJOLSEIH-JHQAJZDGSA-N |
CAS Registry41136-22-5 |
| KEGG | Wiki | ATC | Drug Bank |
|---|---|---|---|
| D01517 | Ceftezole Sodium |
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Bacterial Infections | - | - | - |
| Peritonitis | China | - | |
| Respiratory Tract Infections | China | - | |
| Sepsis | China | - | |
| Urinary Tract Infections | China | - |





